Provenance du réseau au premier degré de Alex Ng
Entité | Type d'entité | Industrie | |
---|---|---|---|
GC Therapeutics, Inc.
GC Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services GC Therapeutics, Inc. is a company based in Cambridge, MA. GC Therapeutics uses synthetic biology to program stem cells into any cell type with efficiency, speed, and scalability. The company has validated cells for many applications and have developed supercells™ by tailoring cells for specific diseases. The company's goal is to bring this breakthrough approach to patients. The company was founded in 2019 by Parastoo Khoshakhlagh, Alex Ng, Cory Smith, and George McDonald Church, with Parastoo Khoshakhlagh as the CEO since 2019.
4
| Holding Company | Miscellaneous Commercial Services | 4 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Alex Ng via son réseau personnel
Société | Secteur | Personnes liées | Poste principal |
---|---|---|---|
Harvard University
Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Graduate Degree | |
Stanford University | College/University | Doctorate Degree | |
Massachusetts Institute of Technology | College/University | Undergraduate Degree | |
Harvard Medical School | College/University | Corporate Officer/Principal | |
BiVACOR, Inc.
BiVACOR, Inc. Medical SpecialtiesHealth Technology BiVACOR, Inc. develops and manufactures medical device. The firm specializes in rotary blood pumps, biomedical engineering. The company was founded by Daniel Timms in 2008 and is headquartered in Houston, TX. | Medical Specialties | Director/Board Member | |
Stanford University School of Medicine | College/University | Doctorate Degree | |
Expansion Therapeutics, Inc.
Expansion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Expansion Therapeutics, Inc. manufactures pharmaceutical products. The company is headquartered in Del Mar, CA. | Pharmaceuticals: Major | Director/Board Member | |
Cormorant Asset Management LLC/Private Equity/
Cormorant Asset Management LLC/Private Equity/ Investment ManagersFinance Cormorant Asset Management LLC/Private Equity/ (Cormorant Asset Management) is a venture capital subsidiary of Cormorant Asset Management LP founded in 2013 by Bi Hua Chen. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Private Equity Investor | |
Arkuda Therapeutics, Inc.
Arkuda Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Arkuda Therapeutics, Inc. engages in development of medicines to improve the lives of patients with neurological diseases. It leverages insights into progranulin and lysosomal biology to develop medicines to change the trajectory of neurodegenerative disease. The company was founded by Gerhard Koenig and Duane Burnett in 2018 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Director/Board Member | |
Tympanogen, Inc.
Tympanogen, Inc. Medical SpecialtiesHealth Technology Tympanogen, Inc. develops innovative devices for the ear, nose, and throat. The company is based in Richmond, VA. The company was founded in 2014 by Parastoo Khoshakhlagh, Jesse Ranney, Elaine Horn-Ranney. Elaine Horn-Ranney has been the CEO since 2014. | Medical Specialties | Founder | |
ONK Therapeutics Ltd.
ONK Therapeutics Ltd. BiotechnologyHealth Technology ONK Therapeutics Ltd. develops bio cells for anti cancer therapies. The company was founded by Michael O'Dwyer and Anthony Killarney in 2015 and is headquartered in Galway, Ireland. | Biotechnology | Director/Board Member | |
Garuda Therapeutics, Inc.
Garuda Therapeutics, Inc. BiotechnologyHealth Technology Garuda Therapeutics, Inc. aims to eliminate the need for donor or patient cells for blood stem cell transplants. The company is based in Natick, MA. The company's platform technology generates off-the-shelf, self-renewing blood stem cells that are HLA-compatible and transgene-free. This technology could potentially provide curative therapies for over 120 diseases. Garuda Therapeutics was founded by Dhvanit Shah, Sean Morrison, and David T. Scadden, with Dhvanit Shah serving as CEO since incorporation. | Biotechnology | Director/Board Member | |
Rapport Therapeutics, Inc.
Rapport Therapeutics, Inc. BiotechnologyHealth Technology Rapport Therapeutics, Inc. engages in the discovery and development of transformational small molecule medicines for patients suffering from central nervous system disorders. It develops the RAP (receptor associated proteins) technology platform. The company was founded by Steven M. Paul and David Bredt in February 2022 and is headquartered in Boston, MA. | Biotechnology | Director/Board Member |
Statistiques
Internationale
Etats-Unis | 13 |
Irlande | 2 |
Sectorielle
Health Technology | 8 |
Consumer Services | 5 |
Finance | 3 |
Opérationnelle
Director/Board Member | 8 |
Founder | 3 |
Corporate Officer/Principal | 2 |
Doctorate Degree | 2 |
Chief Executive Officer | 1 |
Relations les plus connectées
Insiders | |
---|---|
Raymond Kelleher | 13 |
Parastoo Khoshakhlagh | 2 |
Cory Smith | 1 |
Brett Losen | 1 |